Emergence of high-level azithromycin-resistant Neisseria gonorrhoeae causing male urethritis in Johannesburg, South Africa, 2021
Etienne E. Müller
A * , Lindy Y. E. Gumede A , Dumisile V. Maseko A , Mahlape P. Mahlangu A , Johanna M. E. Venter A , Bianca Da Costa Dias A , Duduzile Nhlapho A and Ranmini S. Kularatne A B C
A
B
C Present address:
Abstract
In South Africa, Neisseria gonorrhoeae, which is the predominant cause of male urethritis, is treated syndromically using dual ceftriaxone and azithromycin therapy. We determined antimicrobial susceptibilities of N. gonorrhoeae isolates from urethral discharge specimens, and genetically characterised those with elevated minimum inhibitory concentrations (MICs) for first-line antimicrobials.
Routine antimicrobial susceptibility testing (AST) of N. gonorrhoeae isolates included E-test for ceftriaxone, cefixime and gentamicin and agar dilution for azithromycin and spectinomycin. Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) was performed for isolates with elevated MICs to identify antimicrobial resistance (AMR) determinants, and Neisseria gonorrhoeae Multi-Antigen Sequence Typing (NG-MAST) was used to determine strain relatedness.
N. gonorrhoeae was cultured from urethral discharge swab specimens obtained from 196 of 238 (82.4%) men presenting to a primary healthcare facility in Johannesburg in 2021. All viable isolates were susceptible to extended-spectrum cephalosporins. Four isolates had high azithromycin MICs ranging from 32 mg/L to >256 mg/L and grouped into two novel NG-MAST and NG-STAR groups. Two isolates from Group 1 (NG-MAST ST20366, NG-STAR ST4322) contained mutated mtrR (G45D) and 23S rRNA (A2059G) alleles, while the two isolates from Group 2 (NG-MAST ST20367, NG-STAR ST4323) had different mutations in mtrR (A39T) and 23S rRNA (C2611T).
We report the first cases of high-level azithromycin resistance in N. gonorrhoeae from South Africa. Continued AMR surveillance is critical to detect increasing azithromycin resistance prevalence in N. gonorrhoeae, which may justify future modifications to the STI syndromic management guidelines.
Keywords: antimicrobials, azithromycin, ceftriaxone, gonorrhoea, NG-MAST, NG-STAR, resistance, sub-Saharan Africa, urethritis.
References
1 Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 2014; 27(3): 587-613.
| Crossref | Google Scholar | PubMed |
3 Kularatne R, Maseko V, Gumede L, Kufa T. Trends in Neisseria gonorrhoeae antimicrobial resistance over a ten-year surveillance period, Johannesburg, South Africa, 2008–2017. Antibiotics 2018; 7(3): 58.
| Crossref | Google Scholar |
4 The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints and dosing of antibiotics. 2022. Available at https://www.eucast.org/clinical_breakpoints/ [accessed 14 June 2022]
5 Kularatne R, Maseko V, Mahlangu P, Muller E, Kufa T. Etiological surveillance of male urethritis syndrome in South Africa: 2019 to 2020. Sex Transm Dis 2022; 49(8): 560-564.
| Crossref | Google Scholar | PubMed |
6 Demczuk W, Sidhu S, Unemo M, Whiley DM, Allen VG, Dillon JR, et al. Neisseria gonorrhoeae sequence typing for antimicrobial resistance, a novel antimicrobial resistance multilocus typing scheme for tracking global dissemination of N. gonorrhoeae strains. J Clin Microbiol 2017; 55(5): 1454-1468.
| Crossref | Google Scholar | PubMed |
7 Martin IMC, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis 2004; 189(8): 1497-1505.
| Crossref | Google Scholar | PubMed |
8 Lewis DA, Muller E, Steele L, Sternberg M, Radebe F, Lyall M, et al. Prevalence and associations of genital ulcer and urethral pathogens in men presenting with genital ulcer syndrome to primary health care clinics in South Africa. Sex Transm Dis 2012; 39(11): 880-885.
| Crossref | Google Scholar | PubMed |
10 The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 13.0. 2023. Available at http://www.eucast.org [accessed 19 May 2023]
11 Mann LM, Kirkcaldy RD, Papp JR, Torrone EA. Susceptibility of Neisseria gonorrhoeae to gentamicin – gonococcal isolate surveillance project, 2015–2016. Sex Transm Dis 2018; 45(2): 96-98.
| Crossref | Google Scholar | PubMed |
12 Unemo M, Golparian D, Sanchez-Buso L, Grad Y, Jacobsson S, Ohnishi M, et al. The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. J Antimicrob Chemother 2016; 71(11): 3096-3108.
| Crossref | Google Scholar | PubMed |
13 Fayemiwo SA, Muller EE, Gumede L, Lewis DA. Plasmid-mediated penicillin and tetracycline resistance among Neisseria gonorrhoeae isolates in South Africa: prevalence, detection and typing using a novel molecular assay. Sex Transm Dis 2011; 38(4): 329-333.
| Crossref | Google Scholar | PubMed |
14 Muller EE, Fayemiwo SA, Lewis DA. Characterization of a novel β-lactamase-producing plasmid in Neisseria gonorrhoeae: sequence analysis and molecular typing of host gonococci. J Antimicrob Chemother 2011; 66(7): 1514-1517.
| Crossref | Google Scholar | PubMed |
15 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42(2): 377-381.
| Crossref | Google Scholar | PubMed |
16 Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; 95: 103208.
| Crossref | Google Scholar | PubMed |
17 Hagman KE, Shafer WM. Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae. J Bacteriol 1995; 177(14): 4162-4165.
| Crossref | Google Scholar | PubMed |
18 Shafer WM, Balthazar JT, Hagman KE, Morse SA. Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids. Microbiology (Reading) 1995; 141(4): 907-911.
| Crossref | Google Scholar |
19 Maduna LD, Kock MM, van der Veer BMJW, Radebe O, McIntyre J, van Alphen LB, et al. Antimicrobial resistance of Neisseria gonorrhoeae isolates from high-risk men in Johannesburg, South Africa. Antimicrob Agents Chemother 2020; 64(11): e00906-20.
| Crossref | Google Scholar |
20 Yang Y, Yang Y, Martin I, Dong Y, Diao N, Wang Y, et al. NG-STAR genotypes are associated with MDR in Neisseria gonorrhoeae isolates collected in 2017 in Shanghai. J Antimicrob Chemother 2020; 75(3): 566-570.
| Crossref | Google Scholar | PubMed |
21 Liu Y-H, Wang Y-H, Liao C-H, Hsueh P-R. Emergence and spread of Neisseria gonorrhoeae strains with high-level resistance to azithromycin in Taiwan from 2001 to 2018. Antimicrob Agents Chemother 2019; 63(9): e00773-19.
| Crossref | Google Scholar |
22 Palavecino EL, Kilic A, Schmerer MW, Dobre-Buonya O, Toler C, McNeil CJ. First case of high-level azithromycin-resistant Neisseria gonorrhoeae in North Carolina. Sex Transm Dis 2020; 47(5): 326-328.
| Crossref | Google Scholar | PubMed |
23 Mlynarczyk-Bonikowska B, Majewska A, Malejczyk M, Mlynarczyk G, Majewski S. Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century. Med Microbiol Immunol 2020; 209(2): 95-108.
| Google Scholar | PubMed |
24 Sawatzky P, Demczuk W, Lefebvre B, Allen V, Diggle M, Hoang L, et al. Increasing azithromycin resistance in Neisseria gonorrhoeae due to NG-MAST 12302 clonal spread in Canada, 2015 to 2018. Antimicrob Agents Chemother 2022; 66(3): e0168821.
| Crossref | Google Scholar | PubMed |
25 Miura M, Shigemura K, Osawa K, Nakanishi N, Nomoto R, Onishi R, et al. Genetic characteristics of azithromycin-resistant Neisseria gonorrhoeae collected in Hyogo, Japan during 2015–2019. J Med Microbiol 2022; 71(6): 001533.
| Crossref | Google Scholar |
26 Salmeron P, Moreno-Mingorance A, Trejo J, Amado R, Vinado B, Cornejo-Sanchez T, et al. Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016-18. J Antimicrob Chemother 2021; 76(4): 930-935.
| Google Scholar | PubMed |
27 Rambaran S, Naidoo K, Dookie N, Moodley P, Sturm AW. Resistance profile of Neisseria gonorrhoeae in KwaZulu-Natal, South Africa questioning the effect of the currently advocated dual therapy. Sex Transm Dis 2019; 46(4): 266-270.
| Crossref | Google Scholar | PubMed |
28 Yakobi SH, Pooe OJ. Identification of emerging multidrug-resistant Neisseria gonorrhoeae isolates against five major antimicrobial agent options. Med Sci 2023; 11(2): 28.
| Crossref | Google Scholar |
29 Kakooza F, Golparian D, Matoga M, Maseko V, Lamorde M, Krysiak R, et al. Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20. J Antimicrob Chemother 2023; 78: 1982-1991.
| Crossref | Google Scholar |
30 Lu Z, Tadi DA, Fu J, Azizian K, Kouhsari E. Global status of azithromycin and erythromycin resistance rates in Neisseria gonorrhoeae: a systematic review and meta-analysis. Yale J Biol Med 2022; 95(4): 465-478.
| Google Scholar | PubMed |
31 Sanchez-Buso L, Cole MJ, Spiteri G, Day M, Jacobsson S, Golparian D, et al. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study. Lancet Microbe 2022; 3(6): e452-e463.
| Crossref | Google Scholar | PubMed |
32 Day MJ, Jacobsson S, Spiteri G, Kulishev C, Sajedi N, Woodford N, et al. Significant increase in azithromycin “resistance” and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019. BMC Infect Dis 2022; 22(1): 524.
| Crossref | Google Scholar | PubMed |
33 Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ, Galarza P, et al. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study. Lancet Microbe 2021; 2(11): e627-e636.
| Crossref | Google Scholar | PubMed |
34 Kularatne RS, Kufa T, Gumede L, Maseko DV, Lewis DA. Demographic and behavioral risk factors associated with reduced susceptibility of Neisseria gonorrhoeae to first-line antimicrobials in South African men with gonococcal urethral discharge. Antimicrob Agents Chemother 2021; 65(10): e0038921.
| Crossref | Google Scholar | PubMed |
35 Frank D, Kufa T, Dorrell P, Kularatne R, Maithufi R, Chidarikire T, et al. Evaluation of the national clinical sentinel surveillance system for sexually transmitted infections in South Africa: analysis of provincial and district-level data. S Afr Med J 2023; 113(7): 41-48.
| Crossref | Google Scholar | PubMed |
36 StatsSA. Census 2022. Province Gauteng. Statistics South Africa. Available at https://census.statssa.gov.za/#/province/7/2
37 Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep 2021; 70(4): 1-187.
| Crossref | Google Scholar | PubMed |
38 Fifer H, Saunders J, Soni S, Sadiq ST, FitzGerald M. 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae. Int J STD AIDS 2020; 31(1): 4-15.
| Crossref | Google Scholar | PubMed |
39 Peters RPH, Garrett N, Chandiwana N, Kularatne R, Brink AJ, Cohen K, et al. Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: moving towards best practice. South Afr J HIV Med 2022; 23(1): 1465.
| Crossref | Google Scholar | PubMed |
